Redbud Medical Spa
Redbud Medical Spa
Peptide Therapy

Weight Loss & Metabolic Health

For appetite, body composition, blood sugar, and metabolic function.

Book a Consultation

Semaglutide Therapy for Medical Weight Loss

A proven, GLP-1–based approach to weight loss and metabolic health — prescribed and monitored by our medical team.

Semaglutide is one of the most studied and effective medical weight-loss therapies available today. At Redbud, it’s part of a supervised plan built around your health, your labs, and your long-term goals — never a mail-order shortcut.

What is Semaglutide?

Semaglutide is a GLP-1 receptor agonist — a therapy that mimics a natural hormone your body releases after eating. It’s the active ingredient in FDA-approved medications for weight management and type 2 diabetes.

How it works

After you eat, your gut releases GLP-1, which signals fullness and helps regulate blood sugar. Semaglutide extends and amplifies that signal — reducing appetite, slowing gastric emptying, quieting “food noise,” and improving blood-sugar control, all of which make a calorie deficit easier to sustain.

What it’s used for

Medical weight loss; insulin resistance and metabolic health; appetite dysregulation and persistent cravings; support alongside lifestyle change.

Why patients choose it

Proven, consistent results in large trials; reduced cravings; metabolic benefits beyond the scale; a once-weekly rhythm that fits real life.

What to expect

Most patients notice reduced appetite within the first few weeks. Weight loss is gradual and steady, and the dose is increased slowly to improve tolerability. Your specific plan is individualized during your consultation — we don’t publish dosing online.

Safety & side effects

The most common effects are gastrointestinal (nausea, sometimes vomiting, diarrhea, or constipation), usually strongest early or after a dose increase, and they typically ease as your body adjusts. Because rapid weight loss can cost muscle, we emphasize protein-forward nutrition and resistance training. More serious effects are reviewed individually.

Who is (and isn’t) a candidate

May suit adults with weight-loss or metabolic goals not met by lifestyle change alone. We do not prescribe it with a personal/family history of medullary thyroid carcinoma or MEN2, and we screen for pancreatitis, gallbladder disease, certain GI conditions, and pregnancy.

Regulatory & sourcing status

Semaglutide is FDA-approved as the active ingredient in branded prescription medications. Redbud prioritizes FDA-approved products through licensed pharmacies; the landscape for compounded GLP-1s has shifted as shortages resolved, and we prescribe in line with current FDA guidance.

Last reviewed: 06/07/2026

Tirzepatide Therapy for Weight Loss & Metabolic Health

A dual-action metabolic therapy — often more powerful than semaglutide — guided by our medical team.

Tirzepatide is a next-generation weight-loss and metabolic therapy that works through two pathways at once, making it one of the most effective options available for many patients.

What is Tirzepatide?

Tirzepatide is a dual GIP and GLP-1 receptor agonist — it activates two gut-hormone receptors rather than one. It’s the active ingredient in FDA-approved medications for weight management and type 2 diabetes.

How it works

By engaging both GIP and GLP-1 receptors, tirzepatide enhances appetite suppression, improves how your body uses fuel (“metabolic flexibility”), and supports blood-sugar control — often producing stronger results than single-pathway therapies.

What it’s used for

Weight loss; metabolic syndrome; patients who haven’t responded well to semaglutide.

Why patients choose it

Often more effective than semaglutide; stronger appetite suppression; improved metabolic flexibility.

What to expect

Noticeable appetite reduction early, with more pronounced weight loss over time. Because it’s more potent, careful, gradual titration and monitoring matter even more. Dosing is individualized at your consult.

Safety & side effects

Like semaglutide, the most common effects are gastrointestinal and tend to ease with slow dose escalation. Muscle preservation through nutrition and strength training is a core part of the plan.

Who is (and isn’t) a candidate

Similar screening to semaglutide, including contraindication with a personal/family history of medullary thyroid carcinoma or MEN2, and caution with pancreatitis, gallbladder disease, and pregnancy.

Regulatory & sourcing status

Tirzepatide is FDA-approved as the active ingredient in branded prescription medications (e.g., for weight management and type 2 diabetes). As with semaglutide, the compounding landscape shifted after the shortage resolved; we prioritize FDA-approved products and prescribe per current FDA guidance.

Last reviewed: 06/07/2026

Tesamorelin Therapy for Visceral Fat & Body Composition

A growth-hormone–releasing therapy studied specifically for deep abdominal fat.

Tesamorelin stimulates your body’s own growth hormone to help reduce visceral fat — the deeper, more metabolically active fat around the abdominal organs.

What is Tesamorelin?

Tesamorelin is a growth-hormone-releasing hormone (GHRH) analog. It prompts the pituitary to release growth hormone naturally, rather than supplying hormone directly.

How it works

By increasing natural growth hormone pulses, tesamorelin promotes the breakdown of visceral fat while helping preserve lean muscle.

What it’s used for

Patients explore it for abdominal/visceral fat and overall body composition.

Why patients choose it

It targets deeper, more resistant fat; it tends to preserve lean muscle; it works with your own hormonal signaling.

What to expect

Gradual changes in body composition, typically within a structured protocol with monitoring.

Safety & side effects

Reported effects include joint aches, injection-site reactions, fluid retention, and changes in blood sugar. Because it raises growth hormone, monitoring of IGF-1 and metabolic markers is important.

Who is (and isn’t) a candidate

Determined by consultation and labs. Not appropriate during pregnancy, with active malignancy, or where elevated IGF-1 would be a concern.

Regulatory & sourcing status

Tesamorelin is FDA-approved (as Egrifta / Egrifta SV / Egrifta WR) for one specific indication: reduction of excess abdominal fat in adults with HIV-associated lipodystrophy. Use for body composition outside that population is off-label, and we’ll discuss what that means for you directly.

Last reviewed: 06/07/2026

AOD-9604 Therapy for Stubborn Fat

A targeted fat-metabolism peptide explored as part of a comprehensive body-composition plan.

AOD-9604 is a small fragment of the growth hormone molecule studied for its potential to support fat breakdown without significantly affecting blood sugar.

What is AOD-9604?

It’s a synthetic peptide based on a fragment (the “lipolytic” portion) of human growth hormone.

How it works

In research, AOD-9604 appears to encourage fat metabolism (lipolysis) and discourage fat storage, with little of the blood-sugar effect associated with full growth hormone.

What it’s used for

Patients explore it for stubborn fat and body-composition optimization, usually alongside other strategies.

Why patients choose it

It focuses specifically on fat breakdown and can complement other therapies and lifestyle work.

What to expect

Effects tend to be subtle and cumulative, and it works best alongside nutrition and training — not as a standalone solution.

Safety & side effects

Generally reported as well tolerated, with limited large-scale human data. Medical supervision and honest expectation-setting matter.

Who is (and isn’t) a candidate

Determined by consultation; best suited to patients optimizing an already-solid foundation rather than seeking a primary weight-loss therapy.

Regulatory & sourcing status

AOD-9604 is not FDA-approved as a therapeutic drug and should be considered investigational. We source only through licensed pharmacies and prescribe in line with current regulations.

Last reviewed: 06/07/2026

The Redbud Approach

At Redbud, peptide therapy is never a quick fix. It starts with a consultation and health history, appropriate baseline labs, and an honest conversation about whether this therapy fits your goals. From there we build an individualized plan, monitor your progress and tolerability, and adjust as needed — with attention to your safety and your long-term health. If a therapy isn’t right for you, or a better-studied option exists, we’ll tell you. The goal isn’t just results; it’s safe, sustainable outcomes grounded in good medicine.

Keep Exploring

Other peptides

→

Hormone Optimization & Performance

For energy, recovery, sleep, and lean muscle as natural hormone levels decline.

→

Recovery, Injury & Inflammation

For tissue repair, healing, and chronic inflammation.

→

Brain Health & Cognitive Function

For focus, clarity, memory, mood, and stress.

→

Longevity & Cellular Health

For energy at the cellular level and healthy aging.

→

Sexual Health

For libido and sexual function in men and women.

→

Aesthetic / Skin & Hair

For skin quality, rejuvenation, and hair.

→

Immune Support

For immune regulation, balance, and resilience.

Common questions

Is Semaglutide FDA-approved?
Yes — semaglutide is the FDA-approved active ingredient in branded weight-management and diabetes medications.
How fast are results with Semaglutide?
Reduced appetite in the first few weeks; gradual weight loss over months.
Is this Ozempic/Wegovy?
Those are brand names for semaglutide. We’ll discuss the right FDA-approved option for you.
Will I regain weight if I stop Semaglutide?
Possible — which is why we build sustainable habits alongside the medication.
Is tirzepatide stronger than semaglutide?
In trials it often produces greater weight loss, but the right choice depends on your health and goals.
Is tirzepatide FDA-approved?
Yes, as the active ingredient in branded weight-management and diabetes medications.
What are tirzepatide’s side effects?
Mostly gastrointestinal, especially early or after dose increases.
Is tesamorelin FDA-approved?
Yes, but specifically for HIV-associated lipodystrophy; other body-composition uses are off-label.
Does tesamorelin require monitoring?
Yes — we monitor IGF-1 and metabolic markers.
Will tesamorelin help general weight loss?
It targets visceral fat specifically and is studied in a narrow population; it isn’t a general weight-loss drug.
Is AOD-9604 a weight-loss drug?
It’s explored as a fat-metabolism aid, not a primary weight-loss medication.
Is AOD-9604 FDA-approved?
No — it’s investigational.
Will AOD-9604 work on its own?
It’s best used as part of a comprehensive plan.

This page is for educational purposes only and is not medical advice. Peptide therapies require evaluation by a licensed provider, and individual results vary. Some therapies described here are not FDA-approved and are considered investigational; regulatory status is evolving. Nothing here is intended to diagnose, treat, cure, or prevent any disease.

Medically reviewed by Tanna Donalson, PA-C — 06/07/2026.

Ready to begin?

Book a complimentary consultation to find the right protocol for your goals.

Book Your Consult